Gujarat Exclusive > National-World > COVID-19: New single-day spike in cases, India total surges past 46L

COVID-19: New single-day spike in cases, India total surges past 46L

0
178

COVID-19 tally in India touched 46,59,984 as it recorded the biggest single-day spike in cases with 97,570 new patients getting infected in the last 24 hours. The number of fatalities stands at 77,472 with 1,201 new deaths due to the disease in the last 24 hours.

This is the third consecutive day the country is recording the highest surge in cases. On Friday 96,551 new cases were recorded in 24 hours while 95,735 fresh infections were reported on Thursday.

The highest number of deaths in a single day was recorded on Friday with 1,209 fatalities. So far 36 lakh patients have recovered from the disease while 9.58 lakh cases are still under treatment.

India had a record 81,533 recoveries in the last 24 hours. It now has the second-highest number of cases in the world after the United States.

Also Read:Gujarat retains no 1 spot in startup rankings, 2nd time in a row

A total of 10,91,251 samples were tested on Friday, taking the total number of samples tested to 5.51 crore and the country has a positivity rate of 8.94 %.  India has a recovery rate of 77.77% and a fatality rate of 1.6%.

State-wise COVID-19 data

Maharashtra continues to be the worst affected state with over 10 lakh cases. The state recorded 24,886 new cases and 393 deaths. It has so far recorded 28,724 deaths.

In the last 24 hours, the other states that recorded high COVID-19 cases are Andhra Pradesh (9,999), Karnataka (9,464), Uttar Pradesh (7,016) and Tamil Nadu (5,519).  These four along with Maharashtra are the five worst-affected states in India.

More than 70% of the total active cases of COVID-19 are in nine most affected states, while 69% of the total deaths reported so far are concentrated in Maharashtra, Tamil Nadu, Karnataka, Delhi and Andhra Pradesh.

Meanwhile, the Serum Institute of India has paused new recruitment for its Phase 2 and Phase 3 trials of the Oxford University’s Covishield vaccine. The pause in trials came after a UK volunteer showed adverse symptoms.

Worldwide, over 2.8 crore people have been affected by the pandemic while 9.14 lakh have died due to the disease.

 

To read the latest news in Gujarati click here